Learn what drives our clients and us.
CLIENT AND
AGENCY NEWS
TNI medical: more capital for innovative respiratory disease treatment
The SHS portfolio company TNI medical is receiving further funding in a second financing round. Two new investors - the Portuguese investment firm Pathena and a private [...]
numares expands range of lipid analysis products
Regensburg-based company numares has developed a new test system for use in diagnostic lipid analysis, the AXINON lipoFIT-S100-400. In early 2015, numares launched the AXINON lipoFIT-S100, its [...]
SHS acquires Novo Klinik-Service GmbH
With its fourth fund, the Tübingen based medical technology investor SHS Gesellschaft für Beteiligungsmanagement has acquired all shares of Novo Klinik-Service GmbH. The company is based in [...]
SHS invests in molecular diagnostics specialist GNA Biosolutions
The fund SHS IV has invested in GNA Biosolutions GmbH together with existing and new investors. GNA, a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh [...]
numares technology offers performance and robustness: 500,000 lipoprotein tests in US laboratory
The U.S. based laboratory HEALTH DIAGNOSTIC LABORATORY, Inc. (HDL, Inc.) has performed 500,000 tests for the determination of lipoproteins since the first devices were installed at HDL, [...]
numares announces lipoFIT-S100 market launch
World's first CE-labeled NMR-based in-vitro diagnostic system - This enables diagnostic and research laboratories to measure LP particle concentrations on their own and add advanced lipoprotein analyses [...]